Hong Kong needs cervical screening, say doctors:
This article was originally published in Clinica
Doctors in Hong Kong have called for the introduction of an organised cervical screening programme targeted at high-risk groups, reports the South China Morning Post. Only around 20% of women in Hong Kong undergo regular smear tests, compared with 70% in the US and nearly 80% in Europe. Cervical cancer is striking at an increasingly early age in Hong Kong. The mean age at diagnosis fell from 56.7 in 1992 to 49.9 last year and almost 62% of sufferers are now aged under 50.
You may also be interested in...
Scrip’s on-the-ground team in Asia talks about how the regional and wider pharma industry and policymakers have responded so far to the spreading coronavirus outbreak, with a focus on the expedited development of potential drugs and vaccines.
Oncologic Drugs Advisory Committee votes 6-5 that ramucirumab’s benefit/risk profile is favorable in first-line lung cancer, but 13-2 that pivotal trial data do not support approval of Steba’s vascular-targeted, photodynamic therapy for low-risk prostate cancer.